Ten genes overlapped (Figure 6A) and qRT‐PCR demonstrated that FOXP2 was significantly upregulated in both GC cells after transfecting with miR‐300 inhibitors, illustrating that FOXP2 may become the potential binding target of miR‐300 in GC (Figure 6B). The gene discussed is FOXP2; the disease is gastric cancer.